Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy
Authors:
- Milad SoleimaniMSMilad Soleimani
- Alexander SommaASAlexander Somma
- Tamer KaoudTKTamer Kaoud
- Ria GoyalRGRia Goyal
- Jorge BustamanteJBJorge Bustamante
- Dennis C. WylieDWDennis C. Wylie
- Nisha HolayNHNisha Holay
- Agnieszka LooneyALAgnieszka Looney
- Uma GiriUGUma Giri
- Todd TriplettTTTodd Triplett
- Kevin DalbyKevin Dalby
- Jeanne KowalskiJKJeanne Kowalski
- 17 August 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 21 (10) , 1547-1560
Abstract
The heterogeneity and aggressiveness of triple-negative breast cancer (TNBC) contribute to its early recurrence and metastasis. Despite substantial research to identify effective therapeutic targets, TNBC remains elusive in terms of improving patient outcomes. Here, we report that a covalent JNK inhibitor, JNK-IN-8, suppresses TNBC growth both in vitro and in vivo. JNK-IN-8 reduced colony formation, cell viability, and organoid growth in vitro and slowed patient-derived xenograft and syngeneic tumor growth in vivo. Cells treated with JNK-IN-8 exhibited large, cytoplasmic vacuoles with lysosomal markers. To examine the molecular mechanism of this phenotype, we looked at the master regulators of lysosome biogenesis and autophagy transcription factor EB (TFEB) and TFE3. JNK-IN-8 inhibited TFEB phosphorylation and induced nuclear translocation of unphosphorylated TFEB and TFE3. This was accompanied by an upregulation of TFEB/TFE3 target genes associated with lysosome biogenesis and autophagy. Depletion of both TFEB and TFE3 diminished the JNK-IN-8–driven upregulation of lysosome biogenesis and/or autophagy markers. TFEB and TFE3 are phosphorylated by a number of kinases, including mTOR. JNK-IN-8 reduced phosphorylation of mTOR targets in a concentration-dependent manner. Knockout of JNK1 and/or JNK2 had no impact on TFEB/TFE3 activation or mTOR inhibition by JNK-IN-8 but inhibited colony formation. Similarly, reexpression of either wildtype or drug-nonbinding JNK (C116S) in JNK knockout cells did not reverse JNK-IN-8–induced TFEB dephosphorylation. In summary, JNK-IN-8 induced lysosome biogenesis and autophagy by activating TFEB/TFE3 via mTOR inhibition independently of JNK. Together, these findings demonstrate the efficacy of JNK-IN-8 as a targeted therapy for TNBC and reveal its novel lysosome- and autophagy-mediated mechanism of action.Keywords
All Related Versions
Funding Information
- Cancer Prevention and Research Institute of Texas (RP210088)
- Dell Medical School, University of Texas at Austin
- Cancer Prevention and Research Institute of Texas (RR160093)
This publication has 49 references indexed in Scilit:
- Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)PLOS ONE, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEBAutophagy, 2012
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variationNucleic Acids Research, 2012
- Discovery of Potent and Selective Covalent Inhibitors of JNKChemistry & Biology, 2012
- Characterization of the CLEAR network reveals an integrated control of cellular clearance pathwaysHuman Molecular Genetics, 2011
- A Gene Network Regulating Lysosomal Biogenesis and FunctionScience, 2009
- A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral buddingEMBO Reports, 2008
- The c-jun kinase/stress-activated pathway: Regulation, function and role in human diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Sumoylation of MITF and Its Related Family Members TFE3 and TFEBJournal of Biological Chemistry, 2005